The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCURAY INC | COM | 004397105 | 2,200 | 250,000 | SH | SOLE | 0 | 250,000 | 0 | 0 | |
| ACHILLION PHARMACEUTICALS IN | CALL | 00448Q901 | 1,136 | 150,000 | SH | Call | SOLE | 0 | 150,000 | 0 | 0 |
| ACTAVIS PLC | SHS | G0083B108 | 6,692 | 30,000 | SH | SOLE | 0 | 30,000 | 0 | 0 | |
| AIR METHODS CORP | COM PAR $.06 | 009128307 | 1,033 | 20,000 | SH | SOLE | 0 | 20,000 | 0 | 0 | |
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 4,738 | 75,000 | SH | SOLE | 0 | 75,000 | 0 | 0 | |
| AMAG PHARMACEUTICALS INC | COM | 00163U106 | 2,072 | 100,000 | SH | SOLE | 0 | 100,000 | 0 | 0 | |
| AMICUS THERAPEUTICS INC | COM | 03152W109 | 2,004 | 600,000 | SH | SOLE | 0 | 600,000 | 0 | 0 | |
| ANACOR PHARMACEUTICALS INC | COM | 032420101 | 2,660 | 150,000 | SH | SOLE | 0 | 150,000 | 0 | 0 | |
| ATRICURE INC | COM | 04963C209 | 4,136 | 225,000 | SH | SOLE | 0 | 225,000 | 0 | 0 | |
| BIODELIVERY SCIENCES INTL IN | CALL | 09060J906 | 3,621 | 300,000 | SH | Call | SOLE | 0 | 300,000 | 0 | 0 |
| BIOLASE INC | COM | 090911108 | 660 | 300,000 | SH | SOLE | 0 | 300,000 | 0 | 0 | |
| BOSTON SCIENTIFIC CORP | COM | 101137107 | 5,108 | 400,000 | SH | SOLE | 0 | 400,000 | 0 | 0 | |
| BRUKER CORP | COM | 116794108 | 3,155 | 130,000 | SH | SOLE | 0 | 130,000 | 0 | 0 | |
| CATALYST PHARM PARTNERS INC | COM | 14888U101 | 1,106 | 437,296 | SH | SOLE | 0 | 437,296 | 0 | 0 | |
| COMMUNITY HEALTH SYS INC NEW | COM | 203668108 | 4,537 | 100,000 | SH | SOLE | 0 | 100,000 | 0 | 0 | |
| COOPER COS INC | COM NEW | 216648402 | 5,421 | 40,000 | SH | SOLE | 0 | 40,000 | 0 | 0 | |
| COVIDIEN PLC | SHS | G2554F113 | 2,705 | 30,000 | SH | SOLE | 0 | 30,000 | 0 | 0 | |
| CYNOSURE INC | CL A | 232577205 | 1,063 | 50,000 | SH | SOLE | 0 | 50,000 | 0 | 0 | |
| DEPOMED INC | COM | 249908104 | 1,668 | 120,000 | SH | SOLE | 0 | 120,000 | 0 | 0 | |
| DEPOMED INC | PUT | 249908954 | 1,668 | 120,000 | SH | Put | SOLE | 0 | 120,000 | 0 | 0 |
| DYAX CORP | COM | 26746E103 | 624 | 65,000 | SH | SOLE | 0 | 65,000 | 0 | 0 | |
| EDWARDS LIFESCIENCES CORP | COM | 28176E108 | 1,717 | 20,000 | SH | SOLE | 0 | 20,000 | 0 | 0 | |
| ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 2,154 | 50,000 | SH | SOLE | 0 | 50,000 | 0 | 0 | |
| FLAMEL TECHNOLOGIES SA | SPONSORED ADR | 338488109 | 1,125 | 75,000 | SH | SOLE | 0 | 75,000 | 0 | 0 | |
| GW PHARMACEUTICALS PLC | ADS | 36197T103 | 2,146 | 20,000 | SH | SOLE | 0 | 20,000 | 0 | 0 | |
| HCA HOLDINGS INC | COM | 40412C101 | 2,537 | 45,000 | SH | SOLE | 0 | 45,000 | 0 | 0 | |
| HERON THERAPEUTICS INC | COM | 427746102 | 862 | 70,000 | SH | SOLE | 0 | 70,000 | 0 | 0 | |
| INFINITY PHARMACEUTICALS INC | COM | 45665G303 | 956 | 75,000 | SH | SOLE | 0 | 75,000 | 0 | 0 | |
| INOVIO PHARMACEUTICALS INC | PUT | 45773H951 | 1,081 | 100,000 | SH | Put | SOLE | 0 | 100,000 | 0 | 0 |
| INSMED INC | COM PAR $.01 | 457669307 | 3,996 | 200,000 | SH | SOLE | 0 | 200,000 | 0 | 0 | |
| INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 2,366 | 10,000 | SH | SOLE | 0 | 10,000 | 0 | 0 | |
| MEDIVATION INC | COM | 58501N101 | 6,166 | 80,000 | SH | SOLE | 0 | 80,000 | 0 | 0 | |
| MEDTRONIC INC | COM | 585055106 | 4,782 | 75,000 | SH | SOLE | 0 | 75,000 | 0 | 0 | |
| MYLAN INC | CALL | 628530907 | 7,734 | 150,000 | SH | Call | SOLE | 0 | 150,000 | 0 | 0 |
| NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 1,047 | 70,000 | SH | SOLE | 0 | 70,000 | 0 | 0 | |
| NPS PHARMACEUTICALS INC | CALL | 62936P903 | 1,653 | 50,000 | SH | Call | SOLE | 0 | 50,000 | 0 | 0 |
| NPS PHARMACEUTICALS INC | COM | 62936P103 | 1,322 | 40,000 | SH | SOLE | 0 | 40,000 | 0 | 0 | |
| OCERA THERAPEUTICS INC | COM | 67552A108 | 764 | 100,000 | SH | SOLE | 0 | 100,000 | 0 | 0 | |
| OREXIGEN THERAPEUTICS INC | COM | 686164104 | 1,545 | 250,000 | SH | SOLE | 0 | 250,000 | 0 | 0 | |
| PROSENSA HLDG N V | SHS USD | N71546100 | 2,209 | 175,000 | SH | SOLE | 0 | 175,000 | 0 | 0 | |
| PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 66 | 1,000 | SH | SOLE | 0 | 1,000 | 0 | 0 | |
| RECEPTOS INC | COM | 756207106 | 1,491 | 35,000 | SH | SOLE | 0 | 35,000 | 0 | 0 | |
| REGENERON PHARMACEUTICALS | COM | 75886F107 | 2,119 | 7,500 | SH | SOLE | 0 | 7,500 | 0 | 0 | |
| REVANCE THERAPEUTICS INC | COM | 761330109 | 680 | 20,000 | SH | SOLE | 0 | 20,000 | 0 | 0 | |
| SMITH & NEPHEW PLC | SPDN ADR NEW | 83175M205 | 1,786 | 20,000 | SH | SOLE | 0 | 20,000 | 0 | 0 | |
| SPDR S&P 500 ETF TR | PUT | 78462F953 | 14,679 | 75,000 | SH | Put | SOLE | 0 | 75,000 | 0 | 0 |
| SPECTRANETICS CORP | COM | 84760C107 | 3,263 | 142,600 | SH | SOLE | 0 | 142,600 | 0 | 0 | |
| SYNAGEVA BIOPHARMA CORP | COM | 87159A103 | 3,144 | 30,000 | SH | SOLE | 0 | 30,000 | 0 | 0 | |
| TEVA PHARMACEUTICAL INDS LTD | ADR | 881624209 | 5,242 | 100,000 | SH | SOLE | 0 | 100,000 | 0 | 0 | |
| THERAPEUTICSMD INC | COM | 88338N107 | 1,105 | 250,000 | SH | SOLE | 0 | 250,000 | 0 | 0 | |
| TORNIER N V | SHS | N87237108 | 2,806 | 120,000 | SH | SOLE | 0 | 120,000 | 0 | 0 | |
| UNILIFE CORP NEW | COM | 90478E103 | 888 | 300,000 | SH | SOLE | 0 | 300,000 | 0 | 0 | |
| VENTRUS BIOSCIENCES INC | COM | 922822101 | 262 | 200,000 | SH | SOLE | 0 | 200,000 | 0 | 0 | |
| WRIGHT MED GROUP INC | RIGHT 03/01/2019 | 98235T115 | 82 | 55,150 | SH | SOLE | 0 | 55,150 | 0 | 0 | |